Targeting the relaxin hormonal pathway in prostate cancer

E-ISSN： 1097-0215|137|10|2287-2295

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.10, 2015-11, pp. : 2287-2295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormonal Predictors of Prostate Cancer

Urologia Internationalis, Vol. 79, Iss. 1, 2007-07 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components

THE PROSTATE, Vol. 78, Iss. 5, 2018-04 ,pp. : 343-352

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 29-33

Karger

Access to resources Recommend Favorite

Hormonal Therapy of Prostate Cancer: Is There Any News?

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite